Tumor board simulation improves interdisciplinary decision-making in medical students.


Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 15 06 2024
accepted: 23 07 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

Training of interdisciplinary clinical reasoning and decision-making skills, essential in daily clinical practice in oncological specialties, are still underrepresented in medical education. Therefore, at LMU University Hospital Munich, we implemented a didactically modified tumor board simulation with experts from five different disciplines (medical oncology, pathology, radiation oncology, radiology, and surgery) presenting patient cases into a one-week course on the basic principles of oncology. In this survey, we examined the self-assessed impact of our course on the interdisciplinary decision-making skills of medical students. Between November-December 2023 and January-February 2024, we surveyed two cohorts of medical students in the third year of medical school in our one-week course before and after participating in the tumor board simulation. The objective was to evaluate the self-assessed knowledge in interdisciplinary clinical decision-making, in integrating ethical considerations into clinical reasoning, and in comprehension of various professional viewpoints in interdisciplinary decision-making. Knowledge was assessed using a five-step Likert scale from 1 (no knowledge) to 5 (complete knowledge). The survey was answered by 76 students before and 55 after the simulation, equaling 60-70% of all 100 course participants. Mean knowledge level regarding principles of interdisciplinary clinical decision-making improved significantly in all of the following exemplary aspects: purpose and procedure of tumor boards in clinical practice (from 2.4 ± 1.1 to 4.0 ± 1.0, Spearman's ρ = 0.6, p < 0.001), principles of dealing with ethical challenges in oncology (from 2.4 ± 1.1 to 3.4 ± 1.0, ρ = 0.4, p < 0.001), and principles of shared decision-making in oncology (2.7 ± 1.1 to 3.7 ± 1.0, ρ = 0.4, p < 0.001). Students reported that their skills in clinical decision-making and ability to discuss oncological patient cases from different professional viewpoints improved due to the teaching course. By employing our interdisciplinary one-week course and a didactically modified tumor board simulation featuring experts from various oncological disciplines, medical students' comprehension of interdisciplinary clinical decision-making in oncology improved significantly.

Identifiants

pubmed: 39212783
doi: 10.1007/s00432-024-05908-x
pii: 10.1007/s00432-024-05908-x
pmc: PMC11364642
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407

Informations de copyright

© 2024. The Author(s).

Références

J Am Coll Radiol. 2013 Feb;10(2):135-41
pubmed: 23374691
Nat Med. 2022 Apr;28(4):658-665
pubmed: 35440717
Patient Educ Couns. 2003 May;50(1):43-9
pubmed: 12767584
JAMA Oncol. 2022 Mar 01;8(3):420-444
pubmed: 34967848
Med Teach. 2017 May;39(5):505-511
pubmed: 28440719
BMC Med Ethics. 2022 Mar 19;23(1):29
pubmed: 35305627
Eur J Cancer. 2007 Apr;43(6):1002-10
pubmed: 17329094
JCO Oncol Pract. 2022 Jun;18(6):e907-e914
pubmed: 35157507
Ann Oncol. 2006 Mar;17(3):457-60
pubmed: 16322114
J Cancer Res Clin Oncol. 2023 Nov;149(17):16087-16096
pubmed: 37698680
J Am Coll Radiol. 2016 Oct;13(10):1239-1241
pubmed: 27474420
Anat Sci Educ. 2024 Jan-Feb;17(1):11-23
pubmed: 37850629
Front Surg. 2021 Aug 12;8:690680
pubmed: 34458314
J Multidiscip Healthc. 2018 Jan 19;11:49-61
pubmed: 29403284
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):215-22
pubmed: 17511801
Health Policy. 2015 Apr;119(4):464-74
pubmed: 25271171
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Eur J Hum Genet. 2024 Apr;32(4):381-391
pubmed: 38378794
Acad Med. 2016 Sep;91(9):1217-22
pubmed: 26959224
J Cancer Res Clin Oncol. 2023 May;149(5):1905-1915
pubmed: 35796778
J Cancer Educ. 2024 Aug;39(4):374-382
pubmed: 38448671
Med Educ. 2001 Sep;35(9):867-75
pubmed: 11555225
Acad Med. 2013 Dec;88(12):1798-801
pubmed: 24128642
Strahlenther Onkol. 2022 Jan;198(1):1-11
pubmed: 34786605
J Cancer Educ. 2018 Jun;33(3):500-504
pubmed: 27581433
J Cancer Educ. 2023 Oct;38(5):1501-1508
pubmed: 37058222
ESMO Open. 2016 Sep 29;1(5):e000097
pubmed: 27843641
Ann Oncol. 2006 Aug;17(8):1337-8
pubmed: 16524967
GMS Z Med Ausbild. 2015;32(3):Doc35
pubmed: 26677513
Acad Med. 2015 Jun;90(6):738-43
pubmed: 25539516
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
Med Teach. 2021 Feb;43(2):152-159
pubmed: 33205693
Clin Teach. 2013 Oct;10(5):308-12
pubmed: 24015736
Int J Med Inform. 2018 Jan;109:55-69
pubmed: 29195707
J Cancer Res Clin Oncol. 2023 Sep;149(12):10075-10084
pubmed: 37261525
PLoS One. 2015 Oct 06;10(10):e0139921
pubmed: 26441328
JCO Precis Oncol. 2018 Nov;2:1-14
pubmed: 35135153
J Cancer Res Clin Oncol. 2023 Dec;149(19):17071-17079
pubmed: 37750957
Cancer Treat Rev. 2016 Jan;42:56-72
pubmed: 26643552

Auteurs

Kevin Fink (K)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.
Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.

Marie Forster (M)

Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany.

Matthias Oettle (M)

Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany.
Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.

Marcel Büttner (M)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.

Chukwuka Eze (C)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Lukas Käsmann (L)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.

Amanda Tufman (A)

Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany.
German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.

Diego Kauffmann-Guerrero (D)

Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany.
German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.

Toki A Bolt (TA)

Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany.

Julia Kovacs (J)

Division of Thoracic Surgery, LMU University Hospital Munich, LMU Munich, Munich, Germany.

Jens Neumann (J)

Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.

Johannes Mücke (J)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Sonja Heuser (S)

Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany.

Stefanie Corradini (S)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Franziska Walter (F)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Maximilian Niyazi (M)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.

Claus Belka (C)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.

Martin Dreyling (M)

Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.

Martin R Fischer (MR)

Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany.

Daniel F Fleischmann (DF)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany. Daniel.Fleischmann@med.uni-muenchen.de.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Daniel.Fleischmann@med.uni-muenchen.de.
Bavarian Cancer Research Center (BZKF), Munich, Germany. Daniel.Fleischmann@med.uni-muenchen.de.
German Cancer Research Center (DKFZ), Heidelberg, Germany. Daniel.Fleischmann@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH